Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,276 | -61,269 | -29,458 | -77,480 | -55,019 |
| Depreciation Amortization | 315 | 201 | 90 | 282 | 208 |
| Accounts receivable | -1,776 | -893 | 86 | 2,362 | 3,406 |
| Accounts payable and accrued liabilities | 6,338 | 4,363 | 1,040 | -302 | 764 |
| Other Working Capital | 10,338 | 9,639 | 7,547 | 287 | 652 |
| Other Operating Activity | 4,796 | 2,766 | 1,950 | 11,085 | 6,143 |
| Operating Cash Flow | $-71,265 | $-45,193 | $-18,745 | $-63,766 | $-43,846 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -685 | -676 | -504 | -393 | -197 |
| Investing Cash Flow | $-685 | $-676 | $-504 | $-393 | $-197 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 91,229 | 21,997 | 5,322 | 333 | 207 |
| Financing Cash Flow | $91,229 | $21,997 | $5,322 | $333 | $207 |
| Beginning Cash Position | 142,285 | 142,285 | 142,285 | 205,912 | 205,912 |
| End Cash Position | 161,564 | 118,413 | 128,358 | 142,086 | 162,076 |
| Net Cash Flow | $19,279 | $-23,872 | $-13,927 | $-63,826 | $-43,836 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,265 | -45,193 | -18,745 | -63,766 | -43,846 |
| Capital Expenditure | -685 | -676 | -504 | -393 | -197 |
| Free Cash Flow | -71,950 | -45,869 | -19,249 | -64,159 | -44,043 |